Redvax ^None

Redvax is a Swiss biopharmaceutical company that specializes in developing vaccines for CMV and another undisclosed field. It is a spin-off from Redbiotec AG and is currently in the preclinical stage. Their focus is on creating multi-component virus-like particles and protein assemblies.